Aurinia Pharmaceuticals (AUPH) Net Margin (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Net Margin of 44.21% for Q1 2026, down 83.83% on a QoQ basis from 273.35% in Q4 2025, and up 684.0% year-over-year from 5.64% in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Net Margin (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Net Margin history runs 8 years deep, the most recent figure standing at 44.21% for Q1 2026.
- Quarterly Net Margin rose 684.0% year-over-year to 44.21% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 99.99% (up 8388.0% YoY) and the FY2025 annual result came in at 101.47%, up 9902.0% from the prior year.
- Net Margin was 44.21% for Q1 2026 at Aurinia Pharmaceuticals, down from 273.35% in the prior quarter.
- Across five years, Net Margin topped out at 273.35% in Q4 2025 and bottomed at 174.01% in Q1 2022.
- A 5-year average of 9.62% and a median of 16.12% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin soared 533791 bps — and 2023, when it tumbled 855 bps.
- Aurinia Pharmaceuticals' Net Margin stood at 91.5% in 2022, then jumped by 35 bps to 59.58% in 2023, then jumped by 104 bps to 2.47% in 2024, then surged by 10980 bps to 273.35% in 2025, then tumbled by 84 bps to 44.21% in 2026.
- Business Quant data shows AUPH's Net Margin at 44.21% in Q1 2026, 273.35% in Q4 2025, and 42.96% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 44.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.21% |
| Dec 31, 2025 | 273.35% |
| Sep 30, 2025 | 42.96% |
| Jun 30, 2025 | 30.79% |
| Mar 31, 2025 | 37.37% |
| Dec 31, 2024 | 2.47% |
| Sep 30, 2024 | 21.11% |
| Jun 30, 2024 | 1.26% |
| Mar 31, 2024 | -21.29% |
| Dec 31, 2023 | -59.58% |
| Sep 30, 2023 | -24.67% |
| Jun 30, 2023 | -27.70% |
| Mar 31, 2023 | -76.16% |
| Dec 31, 2022 | -91.50% |
| Sep 30, 2022 | -16.12% |
| Jun 30, 2022 | -125.98% |
| Mar 31, 2022 | -174.01% |
| Dec 31, 2021 | -142.38% |
| Sep 30, 2021 | -342.64% |
| Jun 30, 2021 | -710.12% |